Interference by a non-defective variant of influenza A virus is due to enhanced RNA synthesis and assembly

Virus Research

Volumn 57, Issue 1, 1998, Pages 81-100

  Bailly, Jane E ^a   Brown, Earl G ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Influenza A virus; Interference phenotype; Non defective variant

Indexed keywords

VIRUS PROTEIN; VIRUS RNA;

ARTICLE; INFLUENZA VIRUS A; MESSENGER RNA SYNTHESIS; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; VIRUS ASSEMBLY; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CELL LINE; DOGS; HUMANS; INFLUENZA A VIRUS; RNA, COMPLEMENTARY; RNA, MESSENGER; RNA, VIRAL; RNA-DIRECTED DNA POLYMERASE; TRANSCRIPTION, GENETIC; VARIATION (GENETICS); VIRAL INTERFERENCE; VIRAL PROTEINS; VIRUS ASSEMBLY;

INFLUENZA A VIRUS;

EID: 0031725291     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(98)00086-0     Document Type: Article

References (41)

1. Akkina, R.K., Chambers, T.M., Nayak, D.P., 1984. Mechanism of interference by defective-interfering particles of influenza virus: differential reduction of intracellular synthesis of specific polymerase proteins. Vir. Res. 1, 687-702.
2. Aoki, H., Nishiyama, Y., Tsurumi, T., Shibata, M., Ito, Y., Seo, H., Yoshii, S., Maeno, K., 1984. Mechanism of interference between influenza A/WSN and B/Kanagawa viruses. J. Gen. Virol. 65, 1385-1393.
3. Bangham, C.R.M., Kirkwood, T.B.L., 1990. Defective interfering particles: effects in modulating virus growth and persistence. Virology 179, 821-826.
4. Becker-Andre, M., Halbrook, K., 1989. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids. Res. 17, 9437-9446.
5. Brown, E.G., 1990. Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 is controlled by mutations in genome segments 4, 5, 7 and 8. J. Virol. 64, 4523-4533.
6. Brown, E.G., Dimock, C.F., Hannah, K., 1992. Interference is controlled by segment 2 and possibly by segment 8 of the non-defective interfering influenza variant A/FM/1/47-MA. J. Virol. 66, 6314-6321.
7. Caballero, O.L., Villa, L.L., Simpson, A.J.G., 1995. Low stringency-PCR (LS-PCR) allows entirely internally standardized DNA quantitation. Nucleic Acids Res. 23, 192-193.
8. Chambers, T.M., Webster, R.G., 1991. Protection of chickens from lethal infection by influenza A/Chicken/Pennsylvania/ 1/83 virus: characterization of the protective effect. Virology 183, 427-432.
9. Chomczynski, P., Sacchi, N., 1987. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
10. Class, E.J., Osterhaus, D.M.E., Van Beek, R., De Jong, J.C., Rimmelzwaan, G.F., Senne, D.A., Krauss, S., Shortridge, F., Webster, R.G., 1998. Human influenza A H5N1 virus related to a highly pathogenic avain influenza virus. Lancet 351, 472-477.
11. Cottrez, F., Auriault, C., Capron, A., Groux, H., 1994. Quantitative PCR: validation of the use of a multispecific internal control. Nucleic Acids Res. 22, 2712-2713.
12. Cowley, J.A., 1984. A simple procedure for the analysis of the structural proteins o f influenza and parainfluenza virus involving adsorption to erythrocytes. J. Virol. Methods 8, 9-18.
13. Dimmock, N.J., Beck, S., McLain, L., 1986. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication. J. Gen. Virol. 67, 839-850.
14. Gonzalez, S, Zurcher, T., Ortin, J., 1996. Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res. 24, 4456-4463.
15. Hatada, E., Hasegawa, M., Mukaigawa, J., Shimizu, K., Fukuda, R., 1989. Control of influenza virus gene expression: quantitative analysis of each viral RNA species in infected cells. J. Biochem. 105, 537-546.
16. Honda, A., Ishihama, A., 1997. The molecular anatomy of influenza virus RNApolymerase. Biol. Chem. 378, 483-488.
17. Inokuchi, Y., Hirashima, A., 1987. Interference with viral infection by defective RNA replicase. J. Virol. 61, 3946-3949.
18. Kaverin, N.V., Vanch, N.L., Sklyanskaya, E.I., Amvrosieva, T.V., Petrik, J., Vouk, T.C., 1983. Studies on heterotypic interference between influenza A and B viruses: a differential inhibition of the synthesis of viral proteins and RNA. J. Gen. Virol. 64, 2139-2146.
19. Krug, R.M., Alonso-Caplen, F.V., Julkunen, I., Katze, M., 1989. Expression and replication of the influenza virus genome. In: Krug, R.M. (Ed.), The Influenza Viruses. Plenum, NY, pp. 89-152
20. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
21. Lin, J. H-C., Grandchamp, B., Abraham, N. G., 1991. Quantitation of human erythroid-specific porphobilinogen deaminase mRNA by the polymerase chain reaction. Exp. Ematol. 19, 817-822.
22. Maloy, M.L., Whitaker-Dowling, P., Youngner, J.S., 1994. Dominance of cold-adapted influenza A virus over wild-type viruses is at the level of RNA synthesis. Virology 205, 44-50.
23. Meier, E., Harmison, G.G., Schubert, M., 1987. Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L. J. Virol. 61, 3133-3142.
24. Momose, F., Handa, H., Nagata, K., 1996. Identification of host factors that regulate the influenza virus RNA polymerase activity. Biochimie 78, 1103-1108.
25. Morgan, D.J., Dimmock, N.J., 1992. Defective interfering influenza virus inhibit immuopathological effects of infectious virus in the mouse. J. Virol. 66, 1188-1192.
26. Muller, R., Poch, O., Delarue, M., Bishop, D.H.L., Bouloy, M., 1994. Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly-identified regions conserved in RNA-dependent polymerases. J. Gen. Virol. 75, 1345-1352.
27. Nayak, D.P., Davis, A.R., De, B.K., 1981. Molecular organization of defective interfering influenza viral RNAs and their role in persistent infection. In: Bishop, D.L., Elsevier, R.W. (Eds). Amsterdam, North Holland.
28. Noronha-Blob, L., Schulze, I.T., 1976. Viral interference-mediated selection of a plaque-type variant of influenza virus. Virology 69, 314-322.
29. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Transfer of proteins from SDS gels to solid supports, p. 18.60-18.75. In: Ford, N., Nolan, C. (Eds), Molecular Cloning: A Laboratory Manual. Cold Spring Harbour Press, Cold Spring Harbour.
30. Sanz-Ezquerro, J.J., de la Luna, S., Ortin, J., Nieto, A., 1995. Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J. Virol. 69, 2420-2426.
31. Shimizu, K., Handa, H., Nakada, S., Nagata, K., 1994. Regulation of influenza virus RNA polymerase activity by cellular and viral factors. Nucleic Acid Res. 22, 5047-5053.
32. Smeenk, C., Brown, E.G., 1994. The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J. Virol. 68, 530-534.
33. Smeenk, C.A., Wright, K.E., Burns, B.F., Thaker, A.J., Brown, E.G., 1996. Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/ 47-MA, control different stages in pathogenesis. Virus Res. 44, 79-95.
34. Steiger, M, Demolliere, C., Ahlborn-Laake, L., Mous, J., 1991. Competitive polymerase chain reaction assay for quantitation of HIV-1 DNA and RNA. J. Virol. Methods 34, 149-160.
35. Toyoda, T., Adyshev, D.M., Kobayashi, M., Iwata, A., Ishihama, A., 1996. Molecular assembly of the influenza virus RNA polymerase: determination of the subunit-subunit contact sites. J. Gen. Virol. 77, 2149-2157.
36. von Itzstein, M., Wu, W.-Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Phan, J.V., Smythee, M.L., White, H.F., Oliver, S.W., Colman, P.M., Varghese, J.N., Ryan, D.M., Woods, J.M., Bethell, R.C., Hotham, V.J., Cameron, J.M., Penn, C.R., 1993. Rational design of potent sialidase-based inhbitors of influenza virus replication. Nature 363, 418-423.
37. Whitaker-Dowling, P., Youngner, J.S., 1987. Viral interference-dominance of mutant viruses over wild-type virus in mixed infections. Microbiol. Rev. 51, 179-191.
38. Whitaker-Dowling, P., Lucus, W., Youngner, J.S., 1990. Cold-adapted vaccine strains of influenza A virus act as dominant negative mutants in mixed infections with wild-type influenza virus. Virology 175, 358-364.
39. Whitaker-Dowling, P., Maassab, H.F., Youngner, J., 1992. Dominant-negative mutants as antiviral agents: simultaneous infection with the cold-adapted live-virus vaccine for influenza A protects ferrets from disease produced by wild-type influenza A. J. Infect. Dis. 164, 1200-1202.
40. Whitaker-Dowling, P., Zvolenski, R., Youngner, J.S., 1991. The genes associated with trans-dominance of the influenza A cold-adapted live virus vaccine. Virology 180, 81-87.
41. Zou, S, Brown, E.G., 1992. Identification of sequence elements containing signals for replication and encapsidation of the reovirus M1 genome segment. Virology 186, 377-388.